Lexicon Pharmaceuticals
LXRX
#7233
Rank
ยฃ0.36 B
Marketcap
ยฃ1.00
Share price
1.52%
Change (1 day)
74.83%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2025 (TTM): -ยฃ53.62 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ70.86 Million. In 2024 the company made an earning of -ยฃ0.15 Billion a decrease over its 2023 earnings that were of -ยฃ0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ53.62 Million-64.1%
2024 -ยฃ0.15 Billion13.15%
2023 -ยฃ0.14 Billion73.74%
2022 -ยฃ75.98 Million16.16%
2021 -ยฃ65.41 Million49.82%
2020 -ยฃ43.66 Million-147.19%
2019 ยฃ92.49 M-203.42%
2018 -ยฃ89.45 Million-15.31%
2017 -ยฃ0.11 Billion0.2%
2016 -ยฃ0.11 Billion2920.7%
2015 -ยฃ3.49 Million-95.33%
2014 -ยฃ74.8 Million-3.61%
2013 -ยฃ77.6 Million-5.52%
2012 -ยฃ82.14 Million-4.17%
2011 -ยฃ85.72 Million15.5%
2010 -ยฃ74.21 Million8.36%
2009 -ยฃ68.49 Million-4.81%
2008 -ยฃ71.95 Million28.79%
2007 -ยฃ55.86 Million35.71%
2006 -ยฃ41.17 Million52.91%
2005 -ยฃ26.92 Million-23.89%
2004 -ยฃ35.37 Million-24.19%
2003 -ยฃ46.65 Million-0.48%
2002 -ยฃ46.88 Million44.12%
2001 -ยฃ32.53 Million23.01%
2000 -ยฃ26.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eterna Therapeutics
ERNA
-ยฃ7.08 Million-86.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ3.83 B-7,602.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-ยฃ0.39 Billion 656.31%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.50 B-1,090.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
ยฃ5.28 B-10,447.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-ยฃ20.46 Million-59.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ0.74 B-1,550.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ49.77 M-197.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-ยฃ17.33 Million-66.11%๐Ÿ‡บ๐Ÿ‡ธ USA